- Home
- XMTR vs MDXG Comparison
XMTR vs MDXG Comparison
Compare XMTR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- MDXG
- Stock Information
- Founded
- XMTR 2013
- MDXG 2006
- Country
- XMTR United States
- MDXG United States
- Employees
- XMTR N/A
- MDXG N/A
- Industry
- XMTR Industrial Machinery/Components
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- MDXG Health Care
- Exchange
- XMTR Nasdaq
- MDXG Nasdaq
- Market Cap
- XMTR 1.2B
- MDXG 1.2B
- IPO Year
- XMTR 2021
- MDXG N/A
- Fundamental
- Price
- XMTR $24.82
- MDXG $7.60
- Analyst Decision
- XMTR Buy
- MDXG Strong Buy
- Analyst Count
- XMTR 10
- MDXG 3
- Target Price
- XMTR $34.60
- MDXG $12.00
- AVG Volume (30 Days)
- XMTR 614.1K
- MDXG 535.9K
- Earning Date
- XMTR 05-08-2025
- MDXG 04-29-2025
- Dividend Yield
- XMTR N/A
- MDXG N/A
- EPS Growth
- XMTR N/A
- MDXG N/A
- EPS
- XMTR N/A
- MDXG 0.28
- Revenue
- XMTR $545,529,000.00
- MDXG $348,879,000.00
- Revenue This Year
- XMTR $21.05
- MDXG $10.09
- Revenue Next Year
- XMTR $17.31
- MDXG $11.77
- P/E Ratio
- XMTR N/A
- MDXG $26.93
- Revenue Growth
- XMTR 17.72
- MDXG 8.52
- 52 Week Low
- XMTR $11.08
- MDXG $5.47
- 52 Week High
- XMTR $45.33
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- XMTR 39.72
- MDXG 38.98
- Support Level
- XMTR $25.85
- MDXG $7.84
- Resistance Level
- XMTR $27.57
- MDXG $8.12
- Average True Range (ATR)
- XMTR 1.27
- MDXG 0.24
- MACD
- XMTR 0.39
- MDXG -0.02
- Stochastic Oscillator
- XMTR 37.62
- MDXG 24.05
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.